STEVEN GALLIWAY: Open Payments
NPI 1346295094 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 63 payments from 9 companies in 2025. Trend: 2023 $96 · 2024 $133 · 2025 $1,142
Food & beverage: $1,087Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $396 |
| AstraZeneca Pharmaceuticals LP | 9 | $296 |
| Novo Nordisk Inc | 11 | $172 |
| Exact Sciences Corporation | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $74 |
| Lilly USA, LLC | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Corcept Therapeutics | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: AIRSUPRA, VRAYLAR, QULIPTA, Cologuard Collection Kit, Ozempic, EOHILIA, Rybelsus, MOUNJARO.
Industry payments across MI — which companies pay providers there.
